The Journal of Immunology, Vol 144, Issue 11 4333-4339, Copyright © 1990 by American Association of Immunologists

ARTICLES

T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice

E Cenci, L Romani, A Vecchiarelli, P Puccetti and F Bistoni
Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Italy.

In addition to previous evidence for the roles of T cell-dependent immunity and delayed-type hypersensitivity in acquired resistance to systemic candidosis in mice, in the present study we have investigated the relative contributions of L3T4+ and Lyt-2+ lymphocytes in the protective immunity induced by vaccination with low virulence Candida albicans cells. We have also addressed the issue of the mode of Candida Ag recognition by specific T cells leading to cytokine release. Spleen cells from immunized mice produced high levels of IFN-gamma in vitro in response to Candida Ag, and this activity was abolished only by the combined treatment of the responder population with anti-L3T4 and anti- Lyt-2.2 mAb plus C. Positively selected L3T4+ and Lyt-2+ cells also produced IFN-gamma in vitro, provided accessory cells (plastic-adherent and Thy-1- Ia- splenocytes, respectively) were added to the lymphocyte- yeast cell cocultures. The production of IFN-gamma by purified L3T4+ and Lyt-2+ cells was inhibited by addition of the respective anti-class II and anti-class I H-2 antibody to the cultures. In vivo, administration of anti-L3T4, anti-Lyt-2.2 mAb or a combination of both significantly impaired the resistance of immunized mice to challenge with virulent C. albicans, as manifested by increased recovery of the yeast from the mouse kidneys. A similar effect was observed upon neutralization of endogenous IFN-gamma by treatment with rat mAb. These results suggest that both L3T4+ and Lyt-2+ T cells play a role in acquired immunity to systemic C. albicans infection, and that their activity may involve IFN-gamma-mediated stimulation of candidacidal mechanisms.

This article has been cited by other articles:

				F. Nomanbhoy, C. Steele, J. Yano, and P. L. Fidel Jr. Vaginal and Oral Epithelial Cell Anti-Candida Activity Infect. Immun., December 1, 2002; 70(12): 7081 - 7088. [Abstract] [Full Text] [PDF]

				C. Steele and P. L. Fidel Jr. Cytokine and Chemokine Production by Human Oral and Vaginal Epithelial Cells in Response to Candida albicans Infect. Immun., February 1, 2002; 70(2): 577 - 583. [Abstract] [Full Text] [PDF]

				S. L. Newman and A. Holly Candida albicans Is Phagocytosed, Killed, and Processed for Antigen Presentation by Human Dendritic Cells Infect. Immun., November 1, 2001; 69(11): 6813 - 6822. [Abstract] [Full Text] [PDF]

				C. Steele, J. Leigh, R. Swoboda, H. Ozenci, and P. L. Fidel Jr. Potential Role for a Carbohydrate Moiety in Anti-Candida Activity of Human Oral Epithelial Cells Infect. Immun., November 1, 2001; 69(11): 7091 - 7099. [Abstract] [Full Text] [PDF]

				J. Brieland, D. Essig, C. Jackson, D. Frank, D. Loebenberg, F. Menzel, B. Arnold, B. DiDomenico, and R. Hare Comparison of Pathogenesis and Host Immune Responses to Candida glabrata and Candida albicans in Systemically Infected Immunocompetent Mice Infect. Immun., August 1, 2001; 69(8): 5046 - 5055. [Abstract] [Full Text] [PDF]

				S. Mizutani, M. Endo, T. Ino-ue, M. Kurasawa, Y. Uno, H. Saito, K. Onogi, I. Kato, and K. Takesako CD4+-T-Cell-Mediated Resistance to Systemic Murine Candidiasis Induced by a Membrane Fraction of Candida albicans Antimicrob. Agents Chemother., October 1, 2000; 44(10): 2653 - 2658. [Abstract] [Full Text]

				A. A. Gaspari, R. Burns, A. Nasir, D. Ramirez, R. K. Barth, and C. G. Haidaris CD86 (B7-2), but Not CD80 (B7-1), Expression in the Epidermis of Transgenic Mice Enhances the Immunogenicity of Primary Cutaneous Candida albicans Infections Infect. Immun., September 1, 1998; 66(9): 4440 - 4449. [Abstract] [Full Text] [PDF]

				L. M. Lavigne, L. R. Schopf, C. L. Chung, R. Maylor, and J. P. Sypek The Role of Recombinant Murine IL-12 and IFN-{gamma} in the Pathogenesis of a Murine Systemic Candida albicans Infection J. Immunol., January 1, 1998; 160(1): 284 - 292. [Abstract] [Full Text] [PDF]